Accuracy of circulating adiponectin for predicting gestational diabetes: a systematic review and meta-analysis

Diabetologia

Volumn 59, Issue 4, 2016, Pages 692-699

  Iliodromiti, Stamatina ^a   Sassarini, Jennifer ^a   Kelsey, Thomas W ^b   Lindsay, Robert S ^a   Sattar, Naveed ^a   Nelson, Scott M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Adiponectin; Gestational diabetes; Meta analysis; Prediction; Systematic review

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN;

AGE; AREA UNDER THE CURVE; BODY MASS; DIAGNOSTIC ACCURACY; HUMAN; META ANALYSIS; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; BLOOD; DIABETES, GESTATIONAL; FEMALE; PREGNANCY;

ADIPONECTIN; DIABETES, GESTATIONAL; FEMALE; HUMANS; PREGNANCY;

EID: 84959558892     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3855-6     Document Type: Review

References (51)

1. Casey BM, Lucas MJ, McIntire DD, Leveno KJ (1997) Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynecol 90:869–873
2. Catalano PM, McIntyre HD, Cruickshank JK et al (2012) The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 35:780–786
3. Sepe SJ, Connell FA, Geiss LS, Teutsch SM (1985) Gestational diabetes. Incidence, maternal characteristics, and perinatal outcome. Diabetes 34(Suppl 2):13–16
4. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477–2486
5. Landon MB, Spong CY, Thom E et al (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361:1339–1348
6. NICE (2015) Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. NICE guideline. National Institute for Health and Care Excellence, London
7. Scott DA, Loveman E, McIntyre L, Waugh N (2002) Screening for gestational diabetes: a systematic review and economic evaluation. Health Technol Assess 6:1–161
8. Nasrat HA, Ajabnoor MA, Ardawi MS (1991) Fructosamine as a screening-test for gestational diabetes mellitus: a reappraisal. Int J Gynaecol Obstet 34:27–33
9. Aziz NL, Abdelwahab S, Moussa M, Georgy M (1992) Maternal fructosamine and glycosylated haemoglobin in the prediction of gestational glucose intolerance. Clin Exp Obstet Gynecol 19:235–241
10. Fasshauer M, Bluher M, Stumvoll M (2014) Adipokines in gestational diabetes. Lancet Diabetes Endocrinol 2:488–499
11. Xu J, Zhao YH, Chen YP et al (2014) Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis. TheScientificWorldJournal 2014:926932
12. Georgiou HM, Lappas M, Georgiou GM et al (2008) Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol 45:157–165
13. Paradisi G, Ianniello F, Tomei C et al (2010) Longitudinal changes of adiponectin, carbohydrate and lipid metabolism in pregnant women at high risk for gestational diabetes. Gynecol Endocrinol 26:539–545
14. Lain KY, Daftary AR, Ness RB, Roberts JM (2008) First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol (Oxf) 69:407–411
15. Maitland RA, Seed PT, Briley AL et al (2014) Prediction of gestational diabetes in obese pregnant women from the UK Pregnancies Better Eating and Activity (UPBEAT) pilot trial. Diabet Med 31:963–970
16. Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700
17. Bastani A, Jaberzadeh S (2012) Does anodal transcranial direct current stimulation enhance excitability of the motor cortex and motor function in healthy individuals and subjects with stroke: a systematic review and meta-analysis. Clin Neurophysiol 123:644–657
18. Iliodromiti S, Kelsey TW, Anderson RA, Nelson SM (2013) Can anti-Müllerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab 98:3332–3340
19. Iliodromiti S, Kelsey TW, Wu O, Anderson RA, Nelson SM (2014) The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Hum Reprod Update 20:560–570
20. Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536
21. Sterne JA, Sutton AJ, Ioannidis JP et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343:d4002
22. Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58:882–893
23. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56:1129–1135
24. Cochrane Library (2011) Handbook for DTA reviews. Available from http://srdta.Cochrane.org/handbook-dta-reviews. Accessed 1 June 2015
25. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
26. Rutter CM, Gatsonis CA (2001) A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 20:2865–2884
27. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58:982–990
28. Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA (2007) A unification of models for meta-analysis of diagnostic accuracy studies. Biostat (Oxf, Engl) 8:239–251
29. Ferreira AF, Rezende JC, Vaikousi E, Akolekar R, Nicolaides KH (2011) Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus. Clin Chem 57:609–613
30. Nanda S, Savvidou M, Syngelaki A, Akolekar R, Nicolaides KH (2011) Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn 31:135–141
31. Williams MA, Qiu CF, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA (2004) Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 89:2306–2311
32. Weerakiet S, Lertnarkorn K, Panburana P, Pitakitronakorn S, Vesathada K, Wansumrith S (2006) Can adiponectin predict gestational diabetes? Gynecol Endocrinol 22:362–368
33. Gao XL, Yang HX, Zhao Y (2008) Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitus. Chin Med J (Engl) 121:701–705
34. Savvidou M, Nelson SM, Makgoba M, Messow CM, Sattar N, Nicolaides K (2010) First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures. Diabetes 59:3017–3022
35. Ianniello F, Quagliozzi L, Caruso A, Paradisi G (2013) Low adiponectin in overweight/obese women: association with diabetes during pregnancy. Eur Rev Med Pharmacol Sci 17:3197–3205
36. Lacroix M, Battista MC, Doyon M et al (2013) Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus. Diabetes Care 36:1577–1583
37. Rasanen JP, Snyder CK, Rao PV et al (2013) Glycosylated fibronectin as a first-trimester biomarker for prediction of gestational diabetes. Obstet Gynecol 122:586–594
38. Hedderson MM, Darbinian J, Havel PJ et al (2013) Low prepregnancy adiponectin concentrations are associated with a marked increase in risk for development of gestational diabetes mellitus. Diabetes Care 36:3930–3937
39. Fischer JE, Bachmann LM, Jaeschke R (2003) A readers’ guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med 29:1043–1051
40. Li S, Shin HJ, Ding EL, van Dam RM (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302:179–188
41. Yadav A, Kataria MA, Saini V, Yadav A (2013) Role of leptin and adiponectin in insulin resistance. Clin Chim Acta 417:80–84
42. Cnop M, Havel PJ, Utzschneider KM et al (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459–469
43. Sattar N, Wannamethee SG, Forouhi NG (2008) Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? Diabetologia 51:926–940
44. Yeral MI, Ozgu-Erdinc AS, Uygur D, Seckin KD, Karsli MF, Danisman AN (2014) Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial. Endocrine 46:512–518
45. Irwig L, Tosteson AN, Gatsonis C et al (1994) Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 120:667–676
46. Khan KS, Dinnes J, Kleijnen J (2001) Systematic reviews to evaluate diagnostic tests. Eur J Obstet Gynecol Reprod Biol 95:6–11
47. Gatsonis C, Paliwal P (2006) Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer. Am J Roentgenol 187:271–281
48. Deeks JJ (2001) Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ 323:157–162
49. Lijmer JG, Mol BW, Heisterkamp S et al (1999) Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 282:1061–1066
50. Randox (2015) Randox adiponectin—key benefits. Available from www.randox.com/reagents/adiponectin. Accessed 1 June 2015
51. O'Sullivan JB, Mahan CM, Charles D, Dandrow RV (1973) Screening criteria for high-risk gestational diabetic patients. Am J Obstet Gynecol 116:895–900